Literature DB >> 12105319

Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma.

T J Postma1, M Klein, C C P Verstappen, J E C Bromberg, M Swennen, J A Langendijk, M J B Taphoorn, P Scheltens, B J Slotman, H M van der Ploeg, N K Aaronson, J J Heimans.   

Abstract

Abnormalities on CT or MRI and neuropsychological performance in patients with low-grade glioma, with (n = 23) or without (n = 16) prior cerebral radiotherapy, were evaluated. Cerebral atrophy was observed in 14 of 23 patients (61%) treated with prior radiotherapy, and in 1 of 16 patients (6%) without prior radiotherapy. White matter abnormalities were observed in six patients, all of whom were treated with prior radiotherapy. These radiologic cerebral abnormalities correlated with cognitive performance.

Entities:  

Mesh:

Year:  2002        PMID: 12105319     DOI: 10.1212/wnl.59.1.121

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.

Authors:  Sanath Kumar; Ali S Arbab; Rajan Jain; Jinkoo Kim; Ana C deCarvalho; Adarsh Shankar; Tom Mikkelsen; Stephen L Brown
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

2.  Imaging neurotoxicity: is a picture worth a thousand words?

Authors:  Denise D Correa; Lauren E Abrey
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

3.  Cognitive functions in low-grade gliomas: disease and treatment effects.

Authors:  Denise D Correa; Lisa M DeAngelis; Weiji Shi; Howard T Thaler; Michael Lin; Lauren E Abrey
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

4.  Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Authors:  Denise D Correa; Weiji Shi; Lauren E Abrey; Lisa M Deangelis; Antonio M Omuro; Mariel B Deutsch; Howard T Thaler
Journal:  Neuro Oncol       Date:  2011-10-19       Impact factor: 12.300

5.  Computer-based assessment of cognitive functions in brain tumor patients.

Authors:  Klaus Fliessbach; Sabine Rogowski; Christian Hoppe; Michael Sabel; Mathias Goeppert; Christoph Helmstaedter; Pasquale Calabrese; Gabriele Schackert; Joerg-Christian Tonn; Matthias Simon; Uwe Schlegel
Journal:  J Neurooncol       Date:  2010-05-07       Impact factor: 4.130

Review 6.  Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity.

Authors:  Harsha Prasada Lashkari; Srdjan Saso; Lucas Moreno; Thanos Athanasiou; Stergios Zacharoulis
Journal:  J Neurooncol       Date:  2011-07-05       Impact factor: 4.130

7.  Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.

Authors:  A Smits; E Westerberg; D Ribom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-21       Impact factor: 9.236

Review 8.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

9.  Brain irradiation: effects on normal brain parenchyma and radiation injury.

Authors:  Pia C Sundgren; Yue Cao
Journal:  Neuroimaging Clin N Am       Date:  2009-11       Impact factor: 2.264

10.  Longitudinal cognitive follow-up in low grade gliomas.

Authors:  Denise D Correa; Weiji Shi; Howard T Thaler; Angeles M Cheung; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Neurooncol       Date:  2007-10-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.